Andrew Miller

Andrew Miller

Director/Board Member at KYVERNA THERAPEUTICS, INC.

Net worth: - $ as of 2026-08-30

44 year
Health Technology
Finance
Consumer Services

Profile

Dr. Andrew Miller is an Independent Director at Kyverna Therapeutics, Inc., an Associate at PureTech Health LLC and a Chairman at Progentos Therapeutics, Inc. He is on the Board of Directors at Alto Neuroscience, Inc., Kyverna Therapeutics, Inc., Entrega, Inc. and Montara Therapeutics, Inc. Dr. Miller was previously employed as a Chief Operating Officer & Vice President by Tal Medical, Inc., a COO & President-Research & Development by Karuna Therapeutics, Inc., and a Vice President by PureTech Health Plc.
He received his undergraduate degree from the University of Illinois At Urbana–Champaign and a doctorate degree from Massachusetts Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-14 0 ( -.--% ) - $ 2026-08-30
2026-05-26 0 ( -.--% ) - $ 2026-08-30

Andrew Miller active positions

CompaniesPositionStart
KYVERNA THERAPEUTICS, INC. Director/Board Member 2026-02-23
ALTO NEUROSCIENCE, INC. Director/Board Member 2026-05-26
Private Equity Analyst -
Director/Board Member 2013-11-30

Former positions of Andrew Miller

CompaniesPositionEnd
KARA THER Chief Executive Officer 2012-03-31
PURETECH HEALTH PLC Corporate Officer/Principal 2016-06-30
Founder -
See the detail of Andrew Miller's experience

Training of Andrew Miller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Finance

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology